purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents

Chapter 1 Vaccine Adjuvants Market Overview
1.1 Vaccine Adjuvants Definition
1.2 Global Vaccine Adjuvants Market Size Status and Outlook (2018-2032)
1.3 Global Vaccine Adjuvants Market Size Comparison by Region (2018-2032)
1.4 Global Vaccine Adjuvants Market Size Comparison by Type (2018-2032)
1.5 Global Vaccine Adjuvants Market Size Comparison by Application (2018-2032)
1.6 Global Vaccine Adjuvants Market Size Comparison by Sales Channel (2018-2032)
1.7 Vaccine Adjuvants Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Vaccine Adjuvants Market
Chapter 2 Vaccine Adjuvants Market Competition by Player
2.1 Global Vaccine Adjuvants Sales and Market Share by Player (2021-2023)
2.2 Global Vaccine Adjuvants Revenue and Market Share by Player (2021-2023)
2.3 Global Vaccine Adjuvants Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Vaccine Adjuvants Market Segment by Type
3.1 Global Vaccine Adjuvants Market by Type
3.1.1 Oral
3.1.2 Subcutaneous
3.1.3 Intramuscular
3.1.4 Others
3.2 Global Vaccine Adjuvants Sales and Market Share by Type (2018-2023)
3.3 Global Vaccine Adjuvants Revenue and Market Share by Type (2018-2023)
3.4 Global Vaccine Adjuvants Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Vaccine Adjuvants Market Segment by Application
4.1 Global Vaccine Adjuvants Market by Application
4.1.1 Veterinary Vaccine Adjuvants
4.1.2 Human Vaccine Adjuvants
4.2 Global Vaccine Adjuvants Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Vaccine Adjuvants Market Segment by Sales Channel
5.1 Global Vaccine Adjuvants Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Vaccine Adjuvants Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Vaccine Adjuvants Market Segment by Region & Country
6.1 Global Vaccine Adjuvants Market Size and CAGR by Region (2018-2032)
6.2 Global Vaccine Adjuvants Sales and Market Share by Region (2018-2023)
6.3 Global Vaccine Adjuvants Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Vaccine Adjuvants Market Share by Type
6.4.3 North America Vaccine Adjuvants Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Vaccine Adjuvants Market Share by Type
6.5.3 Europe Vaccine Adjuvants Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Vaccine Adjuvants Market Share by Type
6.6.3 Asia-Pacific Vaccine Adjuvants Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Vaccine Adjuvants Market Share by Type
6.7.3 South America Vaccine Adjuvants Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Vaccine Adjuvants Market Share by Type
6.8.3 Middle East & Africa Vaccine Adjuvants Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Vaccine Adjuvants Players
7.1 SEPPIC
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 SDA BIO
7.3 Brenntag Biosector
7.4 SPI Pharma
7.5 MVP Laboratories
7.6 Tj Kaiwei
7.7 Novavax
7.8 Zhuoyue
7.9 Aphios
7.10 GSK
7.11 CSL Limited
7.12 Brenntag Biosector
7.13 SEPPIC
7.14 SPI Pharma
7.15 Novavax
7.16 Avanti Polar Lipids
7.17 Aphios
Chapter 8 Upstream and Downstream Analysis of Vaccine Adjuvants
8.1 Industrial Chain of Vaccine Adjuvants
8.2 Upstream of Vaccine Adjuvants
8.3 Downstream of Vaccine Adjuvants
Chapter 9 Development Trend of Vaccine Adjuvants (2024-2032)
9.1 Global Vaccine Adjuvants Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Vaccine Adjuvants Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Vaccine Adjuvants Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Vaccine Adjuvants Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Vaccine Adjuvants Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification